RNA biotech Arc­turus boots CEO Joseph Payne

Just a few months af­ter do­ing a string of RNA deals with J&J, Cure­Vac and oth­ers in the wake of a re­verse merg­er on­to Nas­daq, Arc­turus $ARCT CEO Joseph Payne is out.

In a state­ment out this morn­ing the com­pa­ny said that the board had de­cid­ed to ter­mi­nate Payne, go­ing on­ly so far as to rule out op­er­a­tional per­for­mance, on­go­ing pro­grams, fi­nan­cial con­di­tion or fi­nan­cial re­port­ing as caus­es.

BD chief Mark Her­bert has been named in­ter­im pres­i­dent un­til a per­ma­nent re­place­ment is found.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.